No Guts, No Loss: Toward the Ideal Treatment for Obesity in the Twenty-First Century
Over the last century, our knowledge of the processes which control appetite and weight regulation has developed significantly. The understanding of where gut hormones fit into the control of energy homeostasis in addition to the rapid advancement of pharmacotherapeutics has paved the way for the de...
Main Authors: | David C. D. Hope, Tricia M. M. Tan, Stephen R. Bloom |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-08-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fendo.2018.00442/full |
Similar Items
-
Proglucagon-Derived Peptides as Therapeutics
by: Ryan A. Lafferty, et al.
Published: (2021-05-01) -
Partial agonism improves the anti-hyperglycaemic efficacy of an oxyntomodulin-derived GLP-1R/GCGR co-agonist
by: Phil Pickford, et al.
Published: (2021-09-01) -
Investigating the Glucagon Receptor and Glucagon-Like Peptide 1 Receptor Activity of Oxyntomodulin-Like Analogues in Male Wistar Rats
by: Samantha L. Price, MRes, et al.
Published: (2015-12-01) -
From the Incretin Concept and the Discovery of GLP-1 to Today's Diabetes Therapy
by: Jens Juul Holst
Published: (2019-04-01) -
Do Gut Hormones Contribute to Weight Loss and Glycaemic Outcomes after Bariatric Surgery?
by: Dimitris Papamargaritis, et al.
Published: (2021-02-01)